Statistical methods

Altman DG, Bland JM. Statistics notes. Units of analysis. BMJ 1997; 314(7098):1874.
PMID: 9224131

Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000; 355(9209):1064-1069.
PMID: 10744093

Bender R, Grouven U. Logistic regression models used in medical research are poorly presented. BMJ 1996; 313(7057):628.
PMID: 8806274

Berry DA. Interim analyses in clinical trials: classical vs. Bayesian approaches. Stat Med 1985; 4(4):521-526.
PMID: 4089353

Bolton S. Independence and statistical inference in clinical trial designs: a tutorial review. J Clin Pharmacol 1998; 38(5):408-412.
PMID: 9602951

Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Davey SG. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives. Health Technol Assess 2001; 5(33):1-56.
PMID: 11701102

Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Intern Med 1993; 118(3):201-210.
PMID: 8417638

DerSimonian R, Charette LJ, McPeek B, Mosteller F. Reporting on methods in clinical trials. N Engl J Med 1982; 306(22):1332-1337.
PMID: 7070458

Fielding S, MacLennan G, Cook JA, Ramsay CR. A review of RCTs in four medical journals to assess the use of imputation to overcome missing data in quality of life outcomes. Trials 2008; 9:51.
PMID: 18694492 [New]

Ferreira-Gonzalez I, Busse JW, Heels-Ansdell D, Montori VM, Akl EA, Bryant DM, onso-Coello P, Alonso J, Worster A, Upadhye S, Jaeschke R, Schunemann HJ, Permanyer-Miralda G, Pacheco-Huergo V, Domingo-Salvany A, Wu P, Mills EJ, Guyatt GH. Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. BMJ 2007; 334(7597):786.
PMID: 17403713

Geller NL, Pocock SJ. Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners. Biometrics 1987; 43(1):213-223.
PMID: 3567306

Goodman SN, Berlin JA. The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results. Ann Intern Med 1994; 121(3):200-206.
PMID: 8017747

Greenland S. Principles of multilevel modelling. Int J Epidemiol 2000; 29(1):158-167.
PMID: 10750618

He J, Jin Z, Yu D. Statistical reporting in Chinese biomedical journals. Lancet 2009; 373(9681):2091-2093.
PMID: 19446326 [New]

Khan KS, Chien PF, Dwarakanath LS. Logistic regression models in obstetrics and gynecology literature. Obstet Gynecol 1999; 93(6):1014-1020.
PMID: 10362173

Matthews JN, Altman DG. Interaction 3: How to examine heterogeneity. BMJ 1996; 313(7061):862.
PMID: 8870577

Matthews JN, Altman DG. Statistics notes. Interaction 2: Compare effect sizes not P values. BMJ 1996; 313(7060):808.
PMID: 8842080

Montori VM, Busse JW, Permanyer-Miralda G, Ferreira I, Guyatt GH. How should clinicians interpret results reflecting the effect of an intervention on composite endpoints: should I dump this lump? ACP J Club 2005; 143(3):A8.
PMID: 16262212

Murray DM, Varnell SP, Blitstein JL. Design and analysis of group-randomized trials: a review of recent methodological developments. Am J Public Health 2004; 94(3):423-432.
PMID: 14998806

Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Ann Intern Med 1992; 116(1):78-84.
PMID: 1530753

Pocock SJ, Lubsen J. More on subgroup analyses in clinical trials. N Engl J Med 2008; 358(19):2076-2077.
PMID: 18463389

Scales CD, Jr., Norris RD, Preminger GM, Vieweg J, Peterson BL, Dahm P. Evaluating the evidence: statistical methods in randomized controlled trials in the urological literature. J Urol 2008; 180(4):1463-1467.
PMID: 18710745

Steyerberg EW, Bossuyt PM, Lee KL. Clinical trials in acute myocardial infarction: should we adjust for baseline characteristics? Am Heart J 2000; 139(5):745-751.
PMID: 10783203


Page last edited: 23 March 2010